Biotech firm Novavax submits COVID-19 vaccine for approval by Health Canada The regulatory filings include clinical data from a trial of 30,000 participants in the U.S. and Mexico, which found 100% protection against moderate and severe disease and 90.4% efficacy overall, Novavax said. Moderna: FDA delaying decision on its shot for adolescents The U.S. Food and Drug Administration told the company Friday evening that its review could last until January, Moderna said. Intraoperative dexamethasone improves survival of cancer patients Non-immunogenic cancers have best outcomes—according to findings at the Anesthesiology 2021 annual meeting of a large retrospective study comparing 90-day survival. Do patients practicing sun-protection behaviours need to worry about negative effects on bone health? A new study finds no decrease in bone mineral density or increase in osteoporotic fractures. U.S. doctor and lawmaker fined for videoconferencing from operating room Regular TB screening cost effective way to prevent spread in vulnerable areas: study Ontario has enough hospital feedback for mandatory vaccination decision: Elliott 'First of its kind' addictions, mental health treatment centre opens in B.C. In Afghan hospital, unpaid doctors and rigid Taliban clash U.S. FDA paves way for Pfizer COVID-19 vaccinations in young kids First Previous 599 600 601 602 603 Next Last
